Kinnate Biopharma - Ownership and Business Overview

Life ScienceCompany

Kinnate Biopharma Ownership

Who owns Kinnate Biopharma?

.

Kinnate Biopharma Business Overview

Where is Kinnate Biopharma headquartered?

Kinnate Biopharma is headquartered in San Francisco, California.

How many employees does Kinnate Biopharma have?

Kinnate Biopharma has 61 employees.

What sector is Kinnate Biopharma in?

Kinnate Biopharma is a life science company.

When was Kinnate Biopharma founded?

Kinnate Biopharma was founded in 2018.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Kinnate Biopharma

Kinnate Biopharma, Inc.

103 Montgomery Street Suite 150 The Presidio of San Francisco,
San Francisco, California 94129
United States,
(858) 299-4699
www.kinnate.com

Kinnate Biopharma is driven by the urgency of cancer patients who need more effective therapies. The company utilizes deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, which we refer to as our Kinnate Discovery Engine, to develop targeted therapies. Its lead programs include candidates in preclinical development for cancers that are driven by specific oncogenic alterations in either the BRAF kinase gene or in the FGFR2 and FGFR3 kinase genes. To help move programs forward, Kinnate has brought together a management team of precision oncology experts and scientific advisors who publish widely-cited research on topics relevant to the study and treatment of cancer and lead clinical units at experienced precision medicine cancer centers in the United States. Kinnate Biopharma was formed in 2018 and is based in San Francisco, California.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.